Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
对 HR(+)HER2(-) 转移性乳腺癌中 ESR1、PIK3CA、AKT1 和 PTEN 进行全面的基因组分析：治疗过程中的患病率及其在真实世界实践中对内分泌治疗耐药性的预测价值
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07376-w
Bhave, Manali A; Quintanilha, Julia C F; Tukachinsky, Hanna; Li, Gerald; Scott, Takara; Ross, Jeffrey S; Pasquina, Lincoln; Huang, Richard S P; McArthur, Heather; Levy, Mia A; Graf, Ryon P; Kalinsky, Kevin
肿瘤
HER2
肿瘤免疫
AKT1
治疗耐药
乳腺癌
PTEN
AKT
